Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1995-06-07
1999-02-09
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
514570, A61K 31615, A61K 3119
Patent
active
058694714
ABSTRACT:
The present invention provides methods of treating a human or other animal subject afflicted with arthritis, including rheumatoid, arthritis and osteoarthritis, comprising a sixty (60)-day treatment period, comprised of an optional NSAID administration regimen and a phosphonate administration regimen, wherein
REFERENCES:
patent: 3676554 (1972-07-01), McGusty et al.
patent: 3887707 (1975-06-01), Sutton et al.
patent: 4216212 (1980-08-01), Flora et al.
patent: 4264582 (1981-04-01), Flora et al.
patent: 4269828 (1981-05-01), Flora et al.
patent: 4275059 (1981-06-01), Flora et al.
patent: 4282214 (1981-08-01), Flora et al.
patent: 4330530 (1982-05-01), Baker
patent: 4687768 (1987-08-01), Benedict et al.
patent: 4746654 (1988-05-01), Breliere et al.
patent: 4868164 (1989-09-01), Ebetino et al.
patent: 4876247 (1989-10-01), Barbier et al.
patent: 4939130 (1990-07-01), Jaeggi et al.
patent: 4939131 (1990-07-01), Benedict et al.
patent: 5071840 (1991-12-01), Ebetino et al.
patent: 5104863 (1992-04-01), Benedict et al.
patent: 5137880 (1992-08-01), Ebetino et al.
Forys, Victor A., "Etidronate and Osteoarthritis" (Letter to the Editor), Jama 265(21):2807 (Jun. 5, 1991).
McGuire, Mary K.B., "Biochemical Mechanisms in Arthritis", Sep. 1981, p. 265 (Thesis submitted to the University of Sheffield).
Ralston, Stuart H., "Clinical, biochemical, and radiographic effects of aminohydroxpropylidene bisphosphonate treatment in rheumatoid arthritis", Ann. Rheum. Diseases 48(5), pp. 396-399 (May 1989).
Heynen, G., et al., Diphosphonates and Rheumatoid Arthritis (RA), Abstracts. ILAR XVth International Congress of Rheumatology, Paris, France, Jun. 21-27, 1981, Rev. Rhum. Mal. Osteoartic., Special Number: 139 (Jun. 1981).
Lane, Nancy, et al., "Effect of Naproxen on Cancellous Bone in Ovariectomized Rats", Journal of Bone and Mineral Research, vol. 5, No. 10 (1990).
Kimmel, D.B., et al., "Long-Term Effect of Naproxen on Cancellous Bone in Ovariectomized Rats", Bone, 13, pp. 167-172 (1992).
Francis, M.D., et al., "The Effects of Disodium Ethane-1-Hydroxy-1,1-Diphosphonate on Adjuvant Induced Arthritis in Rats", Calcif. Tissue Res. 9, pp. 109-121 (1972).
Bird, H.A., et al., "A clinical and biochemical assessment of etidronate disodium in patients with active rheumatoid arthritis", Clin. Rheumatol. 7(1), pp. 91-94 (1988).
Flora, L., "Comparative Antiinflammatory and Bone Protective Effects of Two Diphosphonates in Adjuvant Arthritis", Arthritis and Rheumatism, vol. 22, No. 4, pp. 340-346 (Apr. 1979).
Couchman, K.G., et al., "The effect of anti-rheumatic drugs on factors from porcine synovium inducing chondrocyte mediated cartilage degradation", Agents and Actions, vol. 19 (1-2), pp. 116-122 (Oct. 1986).
Movsowitz, C., et al., "The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat", J. Lab. Clin. Med. 115(1), pp. 62-68 (Jan. 1990).
Francis Marion David
Hovancik Kristine
Underwood Richard Allen
Clark Karen F.
Henley III Raymond
McMahon Mary Pat
The Proctor & Gamble Company
Winter William J.
LandOfFree
Methods for the treatment of arthritis using phosphonates and NS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of arthritis using phosphonates and NS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of arthritis using phosphonates and NS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948544